TrialClinical and translational science2023

Assessment of pharmacokinetics, safety, and tolerability following twice-daily administration of molnupiravir for 10 days in healthy participants.

Marian Iwamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.